Summary of Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Dec. 31, 2021 USD ($) Segment	Dec. 31, 2020 USD ($)	Mar. 31, 2021 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Number of operating segment | Segment	1
Cash equivalents			$ 0
Research and development	$ 157,591,000	$ 89,019,000
Asset impairment	$ 0	0
Minimum
Summary Of Significant Accounting Policies [Line Items]
Percentage Of Tax Benefit Realized Upon Uncertain Resolution Of Contingency	50.00%
ASU 2020-06
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, early adoption	true
Change in accounting principle, accounting standards update, adoption date	Jan. 01, 2021
Change in accounting principle, accounting standards update, immaterial effect	true
Change in accounting principle, accounting standards update, adopted	true
IPO | Prepaid And Other Current Assets
Summary Of Significant Accounting Policies [Line Items]
Deferred offering costs		2,400,000
COVID-19 | High Capacity Production Equipment | Talis One Cartridges
Summary Of Significant Accounting Policies [Line Items]
Research and development	$ 110,500,000
Pre launch inventory relating to cartridges	11,800,000	0
Pre launch inventory to instrument components research and development expense	21,700,000	$ 7,700,000
Cost incurred during the period for high capacity production	69,600,000
Production equipment acquired not to have alternative future use	$ 96,500,000